Dr. Essam Hamza reports
ROCKET DOCTOR GRANTS STOCK OPTIONS AND RSUS
Rocket Doctor AI Inc. has granted an aggregate 47,013 stock options, exercisable at 71 cents per share and valid for a term of three years, and an aggregate 514,801 restricted share units, valid for a term between one to three years, to consultants and employees of the company and its subsidiaries. The stock options and restricted share units are issued pursuant to the company's share compensation plans and are subject to a statutory hold period of four months and one day from issuance, in addition to vesting provisions.
Additionally, and further to the company's news release dated July 18, 2025, the company has extended the marketing services provided by 45 Degrees, Inc. ("45 Degrees") and Investment Publishing LLC ("Investment Publishing") to provide digital marketing and investor awareness services until September 30, 2026. No additional compensation shall be payable to 45 Degrees or Investment Publishing for the additional services provided.
About Rocket Doctor AI Inc.
Rocket Doctor AI delivers physician-built, artificial-intelligence-powered solutions designed to make high-quality health care accessible throughout the entire patient journey. A cornerstone of the company's proprietary technology is the Global Library of Medicine (GLM), a clinically validated decision support system developed with input from hundreds of physicians worldwide.
Alongside the GLM is Rocket Doctor Inc., and its artificial-intelligence-powered digital health platform and marketplace. Having helped empower over 350 MDs (medical doctors) to provide care to more than 750,000 patient visits, the company's proprietary technology software and systems enable doctors to independently launch and manage their own virtual or hybrid in-person practices -- improving efficiency, restoring autonomy to MDs and expanding patient access to care.
By reducing administrative burdens and ensuring greater consistency in care, the company's technology creates more time for meaningful physician-patient interactions. The company is committed to reaching underserved, rural and remote communities in Canada who often lack access to family doctors and supporting patients on Medicaid and Medicare in the United States. With advanced AI, large language models and connected medical devices, Rocket Doctor AI is redefining modern health care -- making it more scalable, equitable and patient centred.
We seek Safe Harbor.
© 2026 Canjex Publishing Ltd. All rights reserved.